All
Researchers Hope a New Drug Can Help Overcome Immunotherapy Resistance in Metastatic Cancers
December 2nd 2022A recently launched clinical trial of NTX1088 will determine if the novel drug can help overcome immune checkpoint inhibition resistance in patients with locally advanced or metastatic solid tumors.
FDA Fast Tracks Pelareorep Combination for Patients with Subtype of a Pancreatic Cancer
December 2nd 2022The combination of pelareorep, Tecentriq, gemcitabine and Abraxane was granted FDA fast-track designation after demonstrating a 69% objective response rate in patients with advanced/metastatic pancreatic ductal adenocarcinoma.